The Effect of Ultrasound-guided Erector Spinae Block on Postoperative in Patients Undergoing Nephrectomy.
1 other identifier
interventional
30
1 country
1
Brief Summary
The main purpose of this study is to evaluate the postoperative effect of erector spinae block in patients undergoing nephrectomy that causes both visceral and somatic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 6, 2021
CompletedFirst Posted
Study publicly available on registry
January 11, 2021
CompletedStudy Start
First participant enrolled
January 14, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 17, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 17, 2021
CompletedSeptember 1, 2021
August 1, 2021
4 months
January 6, 2021
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Numerical Rating Scale (NRS)
Numerical Rating Scale (NRS) will be used for postoperative evaluation. NRS is a segmented digital version of the visual analog scale. Selecting an integer (0-10 integers) by a responder in (VAS). It is accepted as one dimensional-the measure of pain intensity in adults. The 11-point numerical scale ranges from "0" to "10," representing a pain ("no pain"). 10 ("as bad pain as you can imagine"), or ("the worst pain imaginable").
24 hours
Secondary Outcomes (2)
Recovery analgesia
24 hours
postoperative nausea and vomiting
24 hours
Study Arms (2)
erector spinae group
EXPERIMENTALAll blocks will be done under general anesthesia. Using a 6-10 MHz linear ultrasound (Esaote my-lab 6, Italy). With the ultrasonography device of our clinic, the side of the nephrectomy surgery will be performed with the position of the nephrectomy, and the position (lateral decubitus) is given to the patient. The thoracic 10th vertebra will be found under ultrasound guidance. After the T12 transverse protrusion is seen by sliding 3 cm laterally from the midline, 30 ml of 0.25% Bupivacaine will be injected under the erector spinae muscle above it.
placebo group
PLACEBO COMPARATORNo block transaction will be applied to this group. Only postoperative analgesia methods will be used for this group as specified in the protocol.
Interventions
Administration of local anesthetic under the erector spinae muscle just below the transverse process of the thoracic 12th vertebra
Eligibility Criteria
You may qualify if:
- To undergo partial or total nephrectomy surgery
- To be in ASA I-II classification
- To be between the ages of 18-65.
- Not having problems that prevent erector spinae block application such as local anesthetic drug allergy, infection at the injection site, and structural anomaly.
- Being in good mental and psychological health
- To accept to participate in the study.
You may not qualify if:
- Being in ASA III or IV class with a high risk of anesthesia
- Being outside the age range of 18-65
- Having problems such as local anesthetic drug allergy, infection at the injection site, and structural anomaly prevents block application.
- Not being mentally and psychologically healthy
- Those who are allergic to the active substance, patients using antiepileptic drugs
- Those with severe hepatic and renal failure
- Those who have long-term use of nonsteroidal anti-inflammatory and opioid analgesic,
- Those with diabetes and other neuropathic diseases
- Patients who cannot use patient-controlled analgesia (PCA) device
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Namık Kemal University
Tekirdağ, Süleymanpaşa, 59100, Turkey (Türkiye)
Study Officials
- STUDY CHAIR
Ayhan ŞAHİN
Namık Kemal University Medicine Faculty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Asistant Prof
Study Record Dates
First Submitted
January 6, 2021
First Posted
January 11, 2021
Study Start
January 14, 2021
Primary Completion
May 17, 2021
Study Completion
May 17, 2021
Last Updated
September 1, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- starting after 6 months publication
- Access Criteria
- After publication, sharing will be made according to the journal criteria.
Participant data will be shared as much as the tasks described in the study. A meeting will be held at the end of the research, and the statistical data results will be shared. Dr. Ayhan Şahin is responsible.